We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

17 hedge funds and large institutions have $451K invested in Edesa Biotech in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% less ownership

Funds ownership: 3.5% → 3.4% (-0.09%)

11% less funds holding

Funds holding: 19 → 17 (-2)

11% less capital invested

Capital invested by funds: $507K → $451K (-$56.4K)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$7.08K
2
TRCT
Tower Research Capital (TRC)
New York
+$2.38K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$661
4
Wells Fargo
Wells Fargo
California
+$5

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$19.9K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$2.24K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.37K
4
BlackRock
BlackRock
New York
-$338
5
Morgan Stanley
Morgan Stanley
New York
-$130
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
1
CM Management
Florida
$260K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$66.5K -$2.24K -481 -3%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$59.7K -$1.37K -295 -2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$47K – – –
TRCT
5
Tower Research Capital (TRC)
New York
$8.69K +$2.38K +510 +33%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$7K +$7.08K +1,520 +700%
TWC
7
TD Waterhouse Canada
Ontario, Canada
$611 – – –
Fidelity Investments
8
Fidelity Investments
Massachusetts
$589 +$661 +142 New
Fifth Third Bancorp
9
Fifth Third Bancorp
Ohio
$419 – – –
Morgan Stanley
10
Morgan Stanley
New York
$117 -$130 -28 -50%
GRP
11
Global Retirement Partners
California
$105 – – –
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Quebec, Canada
$80 – – –
Wells Fargo
13
Wells Fargo
California
$71 +$5 +1 +6%
National Bank of Canada
14
National Bank of Canada
Quebec, Canada
$36 – – –
UBS Group
15
UBS Group
Switzerland
$17 -$19.9K -4,279 -100%
AWM
16
AllSquare Wealth Management
New York
$4 – – –
Credit Agricole
17
Credit Agricole
France
$4 – – –
BlackRock
18
BlackRock
New York
– -$338 -74 Closed
GWSA
19
Global Wealth Strategies & Associates
Colorado
– -$32 -7 Closed
Citigroup
20
Citigroup
New York
– -$9 -2 Closed

EDSA Hedge Fund Activity: Q1 2024 in Review

17 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2024, worth a combined $451K — down 11% from $507K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of EDSA and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Royal Bank of Canada, adding an estimated $7.08K. The largest seller was UBS Group, cutting an estimated $19.9K.

  • 17 institutional investors held Edesa Biotech (EDSA) as of Q1 2024, down from 19 in Q4 2023.
  • Funds reported $451K of Edesa Biotech stock for Q1 2024, down 11% quarter-over-quarter.
  • 1 fund opened new Edesa Biotech positions in Q1 2024 and 3 closed out, a net change of -2 holders.
  • The largest Edesa Biotech buyer in Q1 2024 was Royal Bank of Canada, an estimated $7.08K added.
  • The largest Edesa Biotech seller in Q1 2024 was UBS Group, an estimated $19.9K sold.

Based on aggregated 13F filings for Q1 2024.